Delhi HC upholds Bristol Myers' patent for anti-cancer drug Dasatinib, imposes Rs 5L penalty on SP Labs Farhat Nasim9 Nov 2024 5:40 PM ISTNew Delhi: In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug dasatinib and...
Delhi HC restrains Micro Lab from infringing Bristol Myers anticoagulant drug Apixaban Medical Dialogues Team19 Aug 2021 5:07 PM ISTNew Delhi: The Delhi High Court has passed an ex-parte ad- interim injunction restraining Micro Labs Limited from infringing any generic Apixaban...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 5:15 PM ISTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they...
Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk - study Medical Dialogues Team21 Sept 2020 12:45 PM ISTNEW YORK: Bristol Myers Squibb Co's cancer immunotherapy Opdivo in combination with Exelixis Inc's Cabometyx reduced the risk of death by 40% in...
Bristol Myers Squibb Onureg gets USFDA approval to treat Acute Myeloid Leukemia Medical Dialogues Bureau12 Sept 2020 9:15 AM ISTPrinceton: Bristol Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) has approved Onureg (azacitidine 300 mg tablets,...
Bristol Myers, Dragonfly Therapeutics enter global licensing agreement for IL-12 Investigational Immunotherapy Program Ruchika Sharma20 Aug 2020 9:00 AM ISTNew York & Waltham: Bristol Myers Squibb and Dragonfly Therapeutics, Inc., have announced that they have entered into a definitive...
